Development of a Computer-Based Tailored Information Application to Improve HIV-Related Treatment Adherence: Preliminary F...
Medication adherence in HIV<br />Adherence needed to suppress viral replication= 80-95%<br />Typical adherence = 60-70%<br...
Health literacy<br />Knowledge, abilities, and skills required to attain a desired state of health<br />Related to multipl...
IMB Model<br />Information: How meds work, how to cope with side effects<br />Motivation: Social support, depression<br />...
Tailored information<br />Personalization<br />Individualized feedback<br />Enhancing perceived relevance<br />Increases i...
The intervention<br />An overview of topics<br />Instructional theory<br />
A Flash animation provides a preliminary overview of the virus life cycle<br />
The animation emphasizes specific stages in the viral life cycle<br />These stages are later reviewed in discussion of how...
A key aspect of the intervention is interactivity<br />Participant learning is assessed with questions<br />If needed, con...
MEMS<br />Medication Event Monitoring System<br />Adherence indices<br />Taken (e.g.,30 pills in 30 days)<br />Correct (e....
Sample (n = 110)<br />
Results: LifeWindows IMB scale<br />Information<br />F= 7.141, p = 0.001 <br />f = 0.35,  a medium to large effect size<br...
Results: Self Efficacy, Depression<br />Patient-Provider Interaction<br />F= 5.17, p = 0.007; f = 0.29, medium effect<br /...
Results: Adherence<br />Percent Taken<br />Number of doses / month<br />F= 4.21, p = 0.04; f = 0.25, a medium effect<br />...
Conclusions<br />Participation in the intervention is associated with improved<br />Information <br />Behavioral skills <b...
Discussion<br />Preliminary results<br />Study not yet completed<br />Clinical vs. statistical significance<br />Medium ef...
Future directions<br />Other languages<br />Other aspects of treatment adherence<br />Appointments<br />Diet, exercise<br ...
Support:<br />Support for this study was provided by grant R21MH086491 to Dr. Ownby from the National Institute on Mental ...
Collaborators<br />Drenna Waldrop-Valverde, PhD<br />Josh Caballero, PharmD<br />Rosemary Davenport, RN, MSN, ARNP<br />Ro...
Upcoming SlideShare
Loading in …5
×

Development of a Computer-Based Tailored Information Application to Improve HIV-Related Treatment Adherence

1,222 views
944 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,222
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Development of a Computer-Based Tailored Information Application to Improve HIV-Related Treatment Adherence

  1. 1. Development of a Computer-Based Tailored Information Application to Improve HIV-Related Treatment Adherence: Preliminary Findings<br />Raymond L Ownby, MD, PhD<br />Nova Southeastern University<br />Fort Lauderdale FL<br />
  2. 2. Medication adherence in HIV<br />Adherence needed to suppress viral replication= 80-95%<br />Typical adherence = 60-70%<br />Viral suppression  decreased risk of infecting others<br />Viral suppression  better clinical outcomes<br />
  3. 3. Health literacy<br />Knowledge, abilities, and skills required to attain a desired state of health<br />Related to multiple clinical variables<br />Disease control (diabetes)<br />Hospitalization (Medicare data)<br />Death (Medicare data)<br />Medication adherence (HIV)<br />
  4. 4. IMB Model<br />Information: How meds work, how to cope with side effects<br />Motivation: Social support, depression<br />Behavioral Skills: How to remember to take medications, cope with obstacles<br />
  5. 5. Tailored information<br />Personalization<br />Individualized feedback<br />Enhancing perceived relevance<br />Increases impact on patient behavior<br /> 10%+ increase in dietary intake of fruits<br /> 10-15% improvement in adherence in older adults treated for memory problems<br />
  6. 6. The intervention<br />An overview of topics<br />Instructional theory<br />
  7. 7. A Flash animation provides a preliminary overview of the virus life cycle<br />
  8. 8. The animation emphasizes specific stages in the viral life cycle<br />These stages are later reviewed in discussion of how medications work<br />
  9. 9. A key aspect of the intervention is interactivity<br />Participant learning is assessed with questions<br />If needed, content is retaught<br />
  10. 10.
  11. 11.
  12. 12. MEMS<br />Medication Event Monitoring System<br />Adherence indices<br />Taken (e.g.,30 pills in 30 days)<br />Correct (e.g., 1pill/24 hours)<br />Scheduled (e.g.,+/- 2 hours)<br />
  13. 13. Sample (n = 110)<br />
  14. 14.
  15. 15.
  16. 16. Results: LifeWindows IMB scale<br />Information<br />F= 7.141, p = 0.001 <br />f = 0.35, a medium to large effect size<br />Motivation<br />F= 0.75, p = 0.48<br />Behavioral Skills<br />F= 8.64, p< 0.001 <br />f = 0.39, a medium to large effect<br />Based on completers<br />3 drop outs<br />
  17. 17. Results: Self Efficacy, Depression<br />Patient-Provider Interaction<br />F= 5.17, p = 0.007; f = 0.29, medium effect<br />Healthcare Self-efficacy <br />F= 11.71, p = 0.001; f = 0.39, medium to large effect<br />Depression and Social Support<br />Not significant<br />
  18. 18. Results: Adherence<br />Percent Taken<br />Number of doses / month<br />F= 4.21, p = 0.04; f = 0.25, a medium effect<br />Percent Correct<br />Number of doses / day<br />F= 5.31, p = 0.02; f = 0.27, a medium effect<br />
  19. 19. Conclusions<br />Participation in the intervention is associated with improved<br />Information <br />Behavioral skills <br />Self-reported ability to work with clinicians<br />Healthcare self-efficacy<br />Not associated with improved<br />Motivation<br />Social support<br />Mood<br />
  20. 20. Discussion<br />Preliminary results<br />Study not yet completed<br />Clinical vs. statistical significance<br />Medium effect sizes comparable to other behavioral interventions<br />Adjunct to other interventions<br />Pre-post design (no control group)<br />
  21. 21. Future directions<br />Other languages<br />Other aspects of treatment adherence<br />Appointments<br />Diet, exercise<br />Other disorders<br />Diabetes<br />Congestive heart failure<br />
  22. 22. Support:<br />Support for this study was provided by grant R21MH086491 to Dr. Ownby from the National Institute on Mental Health.<br />
  23. 23. Collaborators<br />Drenna Waldrop-Valverde, PhD<br />Josh Caballero, PharmD<br />Rosemary Davenport, RN, MSN, ARNP<br />Robin Jacobs, PhD<br />

×